Almirall, S.A. (BME:ALM)
12.50
-0.08 (-0.64%)
Apr 28, 2026, 1:33 PM CET
Almirall Market Cap
Almirall has a market cap or net worth of €2.7 billion as of April 28, 2026. Its market cap has increased by 34.66% in one year.
Market Cap
2.70B
Enterprise Value
2.71B
Revenue
1.11B
Ranking
n/a
PE Ratio
58.33
Stock Price
€12.50
Market Cap Chart
Since June 20, 2007, Almirall's market cap has increased from 2.37B to 2.70B, an increase of 13.94%. That is a compound annual growth rate of 0.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 2.70B | -2.02% |
| Dec 31, 2025 | 2.76B | 56.88% |
| Dec 31, 2024 | 1.76B | -0.35% |
| Dec 29, 2023 | 1.76B | 7.51% |
| Dec 30, 2022 | 1.64B | -19.23% |
| Dec 30, 2021 | 2.03B | 4.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.58B |
| Laboratorios Farmaceuticos Rovi | 4.15B |
| Pharma Mar | 1.64B |
| Faes Farma | 1.49B |
| Clínica Baviera | 832.96M |
| Prim, S.A. | 225.43M |
| Atrys Health | 220.51M |
| Laboratorio Reig Jofre | 217.37M |